基于线粒体的眼病治疗的现状与未来。
The Present and Future of Mitochondrial-Based Therapeutics for Eye Disease.
机构信息
Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA.
Stanford Cardiovascular Institute, Stanford University School of Medicine, Palo Alto, CA, USA.
出版信息
Transl Vis Sci Technol. 2021 Jul 1;10(8):4. doi: 10.1167/tvst.10.8.4.
Abstract
Mitochondria are viable therapeutic targets for a broad spectrum of ocular diseases.
摘要
线粒体是广泛眼部疾病的可行治疗靶点。
Zotero 插件